Literature DB >> 23883384

Mapping the journey to an HIV vaccine.

Margaret Ackerman1, Galit Alter.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23883384     DOI： 10.1056/NEJMcibr1304437

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Virological features associated with the development of broadly neutralizing antibodies to HIV-1.

Authors:  Penny L Moore; Carolyn Williamson; Lynn Morris
Journal:  Trends Microbiol       Date:  2015-01-05       Impact factor: 17.079

2.  Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

Authors:  Scott M Hammer; Magdalena E Sobieszczyk; Holly Janes; Shelly T Karuna; Mark J Mulligan; Doug Grove; Beryl A Koblin; Susan P Buchbinder; Michael C Keefer; Georgia D Tomaras; Nicole Frahm; John Hural; Chuka Anude; Barney S Graham; Mary E Enama; Elizabeth Adams; Edwin DeJesus; Richard M Novak; Ian Frank; Carter Bentley; Shelly Ramirez; Rong Fu; Richard A Koup; John R Mascola; Gary J Nabel; David C Montefiori; James Kublin; M Juliana McElrath; Lawrence Corey; Peter B Gilbert
Journal:  N Engl J Med       Date:  2013-10-07       Impact factor: 91.245

3.  Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization.

Authors:  Jordan R Willis; Jessica A Finn; Bryan Briney; Gopal Sapparapu; Vidisha Singh; Hannah King; Celia C LaBranche; David C Montefiori; Jens Meiler; James E Crowe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

Review 4.  HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians.

Authors:  Yegor Voronin; Helene Zinszner; Carissa Karg; Katie Brooks; Robert Coombs; John Hural; Renee Holt; Pat Fast; Mary Allen
Journal:  Vaccine       Date:  2015-01-31       Impact factor: 3.641

5.  Directed evolution of a yeast-displayed HIV-1 SOSIP gp140 spike protein toward improved expression and affinity for conformational antibodies.

Authors:  Sebastian K Grimm; Michael B Battles; Margaret E Ackerman
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 6.  Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?

Authors:  Marc H V Van Regenmortel
Journal:  AIMS Public Health       Date:  2015-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.